Key facts
- This page summarizes Charles F. Wagner Jr.'s Form 4 filing for VERTEX PHARMACEUTICALS INC / MA (VRTX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 26 Feb 2026, 18:56.
Charles F. Wagner Jr. - 24 Feb 2026 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)
- Reporting relationship
- EVP, CO & FO
- Issuer ticker
- VRTX
- Reported as of
- 24 Feb 2026
- Net transaction value
- -$846,032
- SEC form
- 4
- Accepted by SEC
- 26 Feb 2026, 18:56:38 UTC
- Prior SEC filing
- 19 Feb 2026
- Next SEC filing
- 11 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christiana Stevenson, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Charles F. Wagner Jr. filed Form 4 for VERTEX PHARMACEUTICALS INC / MA (VRTX) on 26 Feb 2026.
Change
- Previous filing in this sequence was filed on 19 Feb 2026.
- Current net transaction value: -$846,032.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001223348
Primary reporting owner
WAGNER CHARLES F JR
- Relationship
- EVP, CO & FO
- Address
- C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVENUE, BOSTON
- Signature
- /s/ Christiana Stevenson, Attorney-in-Fact
- Signature date
- 26 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VRTX
transaction
Common Stock
Tax liability
- Transaction value
- $846,032
- Shares
- -1,744
- Change %
- -3.6%
- Price
- $485.11
- Shares after
- 47,042
- Date
- 24 Feb 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.